Michelle Dolan, MD

Associate Professor, Department of Laboratory Medicine and Pathology

Michelle Dolan

Contact Info


Office Phone 612-273-5934

Mailing Address:
MMC 609 Mayo
420 Delaware
Minneapolis, MN 55455

University of Minnesota Medical School, 1993

University of Minnesota Medical School, Internship (Internal Medicine), 1995

University of Minnesota Medical Center (Anatomic & Clinical Pathology), 1999

University of Minnesota Medical Center, Chief Resident (Anatomic & Clinical Pathology), 2000

University of Minnesota Medical School (Cytogenetics & Molecular), 2002

College of St. Catherine, Minnesota (English), 1986


Dr. Dolan is a clinical cytogeneticist, associate director of the Cytogenetics Laboratory, and a member of the Division of Molecular Pathology and Genomics.  She currently collaborates in research projects with colleagues in areas as diverse as surgical pathology, hematopathology, oncology and bone marrow transplantation, and oral pathology. She has ongoing collaborations with Dr. Celalettin Ustun in the Division of Hematology, Oncology and Transplantation exploring the impact of cytogenetic findings on hematopoietic stem cell transplant outcomes. These projects have investigated the role of classical (G-banding) and molecular cytogenetics (fluorescence in situ hybridization, FISH) in assessing the level of disease burden before bone marrow or stem cell transplantation.

In another collaboration with Drs. Ustun, Michael Linden (Laboratory Medicine and Pathology) and others in the United States and internationally, Dolan is exploring the role of mast cells in core-binding factor acute myeloid leukemias. Dolan is also working with Dr. Ustun and Drs. Linden, Sophia Yohe and Elizabeth Courville (Laboratory Medicine and Pathology) on a project to determine if residual disease at the time of transplant, as assessed by cytogenetic and other methods, impacts outcomes of various types of pre-transplant conditioning regimens.

Dolan is also collaborating with Dr. Aleksandr Lazaryan and colleagues in the Division of Hematology, Oncology and Transplantation in a study to determine the prognostic significance of cytogenetic abnormalities in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in complete remission.

Dolan is a co-investigator with Dr. Ioannis Koutlas and others in the Department of Oral Pathology in studies designed to determine whether the PLAG1 gene is rearranged in entities other than pleomorphic adenomas arising in salivary glands. She is also working with a colleague at Vanderbilt University on an immunohistochemical and FISH study of Ewing sarcoma and atypical teratoid/rhabdoid tumors.

Awards & Recognition

  • Phi Beta Kappa, 1985
  • Kappa Gamma Pi, 1986
  • St. Paul Court of Honor, 1986
  • Alpha Omega Alpha, 1993
  • Janet M. Glasgow Memorial Achievement Award, 1993

Professional Associations

  • College of American Pathologists
  • American Society of Clinical Pathologists
  • American Society of Human Genetics
  • Association for Molecular Pathology



  • Naumchik B, Weigel BJ, Murati MA, Rudzinski E, Paulson V, Lockwood CM, Dolan M, Flanagan S, Luquette M. Congenital infantile fibrosarcoma involving pelvic wall and thigh soft tissues and placenta, presenting with coagulopathy. Pediatr Dev Pathol. 2022 Jul 14:10935266221114017. doi: 10.1177/10935266221114017.
  • Han SY, Mrózek K, Voutsinas J, Wu Q, Morgan EA, Vestergaard H, Ohgami R, Kluin PM, Kristensen TK, Pullarkat S, Møller MB, Schiefer AI, Baughn LB, Kim Y, Czuchlewski D, Hilberink JR, Horny HP, George TI, Dolan M, Ku NK, Arana Yi C, Pullarkat V, Kohlschmidt J, Salhotra A, Soma L, Bloomfield CD, Chen D, Sperr WR, Marcucci G, Cho C, Akin C, Gotlib J, Broesby-Olsen S, Larson M, Linden MA, Deeg HJ, Hoermann G, Perales MA, Hornick JL, Litzow MR, Nakamura R, Weisdorf D, Borthakur G, Huls G, Valent P, Ustun C, Yeung CCS. Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21). Blood Adv. 2021 May 25;5(10):2481-2489. doi: 10.1182/bloodadvances.2020003605.
  • Erickson BE, Najjar O, Damast S, Blakaj A, Tymon-Rosario J, Shahi M, Santin A, Klein M, Dolan M, Cimino-Mathews A, Buza N, Ferriss JS, Stone RL, Khalifa M, and Fader AN. Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study. Gynecologic Oncology, 2020; 159 (1): 17-22. https://doi.org/10.1016/j.ygyno.2020.07.016.
  • Ustun, C., Morgan, E.A., Ritz, E.M., Vestergaard, H., Pullarkat, S., Kluin, P.M., Ohgami, R., Baughn, L.B., Kim, Y., Ku, N.K., Czuchlewski, D., Boe Møller, M., Schiefer, A.‐I., Mrózek, K., Horny, H.‐P., George, T.I., Kielsgaard Kristensen, T., Beck, T., Nathan, S., Arana Yi, C., Yeung, C., Pullarkat, V., Gotlib, J., Akin, C., Kohlschmidt, J., Salhotra, A., Soma, L., Chen, D., Han, S.Y., Cho, C., Sperr, W., Broesby‐Olsen, S., Linden, M.A., Dolan, M., Hoermann, G., Hornick, J.L., Bloomfield, C., Nakamura, R., Joachim Deeg, H., Litzow, M.R., Borthakur, G., Weisdorf, D., Huls, G., Perales, M.‐A., Valent, P. and Marcucci, G. Core‐binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure. Int J Lab Hematol., 2020. doi:10.1111/ijlh.13338.
  • Gilles SR, Yohe SL, Linden MA, Dolan M, Hirsch B, Grzywacz B. CD161 Is expressed in a subset of T-cell prolymphocytic leukemia cases and Is useful for disease follow-up.Am J Clin Pathol. 2019 Sep 9;152(4):471-478. doi: 10.1093/ajcp/aqz060.
  • Shahi M, Dolan M, Murugan P. Hyalinizing Clear Cell Carcinoma of the Bronchus. Head Neck Pathol. 2017 May 16. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28508996
  • Hagen, P.; Wagner, John E.; Defor, Todd E.; Dolan, M.; Arora, Mukta; Warlick, Erica D.; Weisdorf, Daniel J.; Brunstein, Claudio G. The effect of equine antithymocyte globulin on the outcomes of reduced intensity conditioning for AML. Bone Marrow Transplantation. 2014.
  • Rabenau, Karen E.; Dolan, Michelle M.; Yohe, Sophia L.; Üstün, Celalettin Effectiveness of dasatinib in accelerated-phase chronic myeloid leukemia with p190 BCR-ABL1 and a second Philadelphia chromosome. Cancer Genetics 207(3) 109-100. 2014.
  • Kaplan, Alesia; Samad, Arbaz; Dolan, Michelle M.; Cioc, Adina M.; Holman, Carol J.; Schmechel, Stephen C.; Pambuccian, Stefan E. Follicular lymphoma transformed to "double-hit" B lymphoblastic lymphoma presenting in the peritoneal fluid. Diagnostic Cytopathology 41(11) 986-990, 2013.
  • Argyris, Prokopios P.; Dolan, Michelle M.; Piperi, Evangelia P.; Tosios, Konstantinos I.; Pambuccian, Stefan E.; Koutlas, Ioannis George Oral follicular lymphomas. A short report of 8 cases with assessment of the IGH/BCL2 gene fusion with fluorescence in situ hybridization. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 116(3) 373-347, 2013.
  • Dolan, Michelle M.; Cioc, Adina M.; Cross, Nicholas CP P; Neglia, Joseph P.; Tolar, Jakub Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion. Pediatric Blood and Cancer 59(1) 194-196, 2012.


Board Certifications

  • Minnesota State Medical Licensure
  • American Board of Pathology, Anatomic Clinical Pathology, 2001
  • American Board of Medical Genetics, Clinical Cytogenetics and Clinical Molecular Genetics, 2002